Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)

SHA:603590 Revenue

In the year 2025, Beijing Konruns Pharmaceutical had annual revenue of 915.12M CNY with 10.87% growth. Beijing Konruns Pharmaceutical had revenue of 214.87M in the quarter ending March 31, 2026, with 1.35% growth.

• Revenue: 915.12M
• Revenue Growth: +10.87%
• P/S Ratio: 6.31
• Revenue / Employee: 1.37M
• Employees: 668
• Market Cap: 5.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	915.12M	89.73M	10.87%
Dec 31, 2024	825.40M	-94.61M	-10.28%
Dec 31, 2023	920.01M	53.29M	6.15%
Dec 31, 2022	866.73M	56.94M	7.03%
Dec 31, 2021	809.78M	1.14M	0.14%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error